Authors: Smilde, TJ van Wissen, S Wollersheim, H Kastelein, JJP Stalenhoef, AFH

Citation: Tj. Smilde et al., Genetic and metabolic factors predicting risk of cardiovascular disease infamilial hypercholesterolemia, NETH J MED, 59(4), 2001, pp. 184-195

Authors: Smilde, TJ van Wissen, S Kastelein, JJP Stalenhoef, AFH

Citation: Tj. Smilde et al., Measurement of atherosclerosis progression - Reply, LANCET, 358(9278), 2001, pp. 329-329

Authors: Smilde, TJ van Wissen, S Wollersheim, H Trip, MD Kastelein, JJP Stalenhoef, AFH

Citation: Tj. Smilde et al., Effect of aggressive versus conventional lipid lowering on atherosclerosisprogression in familial hypercholesterolaemia (ASAP): a prospective, randomised, double-blind trial, LANCET, 357(9256), 2001, pp. 577-581

Authors: Smilde, TJ Trip, MD Wollersheim, H van Wissen, S Kastelein, JJP Stalenhoef, AFH

Citation: Tj. Smilde et al., Rationale, design and baseline characteristics of a clinical trial comparing the effects of robust vs conventional cholesterol lowering and intima media thickness in patients with familial hypercholesterolaemia - The Atorvastatin versus Simvastatin on Atherosclerosis Progression (ASAP) study, CLIN DRUG I, 20(2), 2000, pp. 67-79